Quarter report 2/2025 on the location of the chemical-pharmaceutical
Industry / sensitive setback in the chemical business
Frankfurt/Main (ots) –
– Production: strong setback
– producer prices under pressure
– Total sales: weak business at home and abroad
– Outlook: Recovery postponed again
The second quarter of 2025 was for German chemical and Pharmaceutical industry
Overall disappointing. Production, sales and prices went – partly
clearly – back. The hoped -for trend reversal failed to materialize in the domestic business. The
Lack of order even tightened. Many customers from industry throttled
their production and withdrew with chemical orders. The
Chemistry and pharmaceutical business also declined. The decline
However, it was foreseeable here: At the beginning of the year, the important US business occurred
Preduction effects. The exports were temporarily anticipated
Reduced up.
No short -term improvement in sight
How difficult the current situation in the industry is shows in the
Capacity utilization. She collapsed vigorously in the second quarter and only reached
still 71.7 percent – the lowest value since 1991. This remained the utilization
Far below the profitability threshold. An improvement is not in short notice
View. The business expectations have definitely clouded.
VCI general manager Wolfgang Große Entrup commented: “The second quarter
Was another endurance test for the chemistry. Weak demand, falling sales
And a production far below the pre -crisis level – that’s what reality sees at the moment
in our industry and also in large parts of German industry.
Geopolitical crises and political zigzag ignite in the economy. The
Uncertainty in chemical and pharmaceutical companies is huge and paralyzes the business.
The Chancellor’s fire brigade operations on the international floor were correct and
important. In the second 100 days, the government must have the promised
Start spectacular catch -up. Together in the hand and
Deproses the huge bureaucracy and the structural deficits at the location.
Now only acts counts – courageous, fast, determined. “
The numbers at a glance:
– Despite the setback, the VCI sticks to its forecast: the production of the
Chemical and pharmaceutical industry stagnates in 2025. For chemistry
expected a decline of 2 percent. In the case of declining prices, the
Total turnover in the industry then decreased by 1 percent to 221 billion euros.
Neither in Germany nor in abroad is currently being seen
Trend reversal.
– Production fell in the second quarter of 2025 compared to the previous quarter
strong by 3.8 percent. It was 3.1 percent lower than one year
before. The capacity utilization collapsed to 71.7 percent.
– The producer prices were increasingly under pressure. Compared to the previous quarter
the prices of the industry fell by 0.6 percent. So they were 0.2 percent
cheaper than a year earlier.
– The total turnover of the chemical and pharmaceutical industry fell compared to
5.2 percent before quarter. With a value of 52.2 billion euros, it was 2.7
Percent lower than 12 months earlier.
All documents here: https://www.vci.de
The VCI and its specialist associations represent the interests of around 2,300
Companies from the chemical-pharmaceutical industry and chemicals
Economic branches towards politics, authorities, other areas of the economy,
science and the media. In 2024 the member companies of the VCI
Around 240 billion euros and employed over 560,000 employees
Employees.
Press contact:
VCI press office:
Telephone: 069 2556-1496
Email: mailto: [email protected]
The VCI on X and LinkedIn
Further material: http://presseportal.de/pm/12523/6109718
OTS: Association of Chemical Industry (VCI)
